207 related articles for article (PubMed ID: 28508352)
21. CD40 ligand-stimulated B cell precursor leukemic cells elicit interferon-gamma production by autologous bone marrow T cells in childhood acute lymphoblastic leukemia.
Todisco E; Gaipa G; Biagi E; Bonamino M; Gramigna R; Introna M; Biondi A
Leukemia; 2002 Oct; 16(10):2046-54. PubMed ID: 12357356
[TBL] [Abstract][Full Text] [Related]
22. Interactions between acute lymphoblastic leukemia and bone marrow stromal cells influence response to therapy.
Tesfai Y; Ford J; Carter KW; Firth MJ; O'Leary RA; Gottardo NG; Cole C; Kees UR
Leuk Res; 2012 Mar; 36(3):299-306. PubMed ID: 21889797
[TBL] [Abstract][Full Text] [Related]
23. Detection of residual disease in pediatric B-cell precursor acute lymphoblastic leukemia by comparative phenotype mapping: a study of five cases controlled by genetic methods.
Dworzak MN; Stolz F; Fröschl G; Printz D; Henn T; Fischer S; Fleischer C; Haas OA; Fritsch G; Gadner H; Panzer-Grümayer ER
Exp Hematol; 1999 Apr; 27(4):673-81. PubMed ID: 10210325
[TBL] [Abstract][Full Text] [Related]
24. Acute lymphoblastic leukemia cells treated with CpG oligodeoxynucleotides, IL-4 and CD40 ligand facilitate enhanced anti-leukemic CTL responses.
Fabricius D; Breckerbohm L; Vollmer A; Queudeville M; Eckhoff SM; Fulda S; Strauss G; Debatin KM; Jahrsdörfer B; Meyer LH
Leukemia; 2011 Jul; 25(7):1111-21. PubMed ID: 21527935
[TBL] [Abstract][Full Text] [Related]
25. CD58 expression decreases as nonmalignant B cells mature in bone marrow and is frequently overexpressed in adult and pediatric precursor B-cell acute lymphoblastic leukemia.
Lee RV; Braylan RC; Rimsza LM
Am J Clin Pathol; 2005 Jan; 123(1):119-24. PubMed ID: 15762287
[TBL] [Abstract][Full Text] [Related]
26. Bone marrow stromal cells and the upregulation of interleukin-8 production in human T-cell acute lymphoblastic leukemia through the CXCL12/CXCR4 axis and the NF-kappaB and JNK/AP-1 pathways.
Scupoli MT; Donadelli M; Cioffi F; Rossi M; Perbellini O; Malpeli G; Corbioli S; Vinante F; Krampera M; Palmieri M; Scarpa A; Ariola C; Foà R; Pizzolo G
Haematologica; 2008 Apr; 93(4):524-32. PubMed ID: 18322253
[TBL] [Abstract][Full Text] [Related]
27. Selective homing of human leukemic B-cell precursors to specific lymphohematopoietic microenvironments in SCID mice: a role for the beta 1 integrin family surface adhesion molecules VLA-4 and VLA-5.
Messinger Y; Chelstrom L; Gunther R; Uckun FM
Leuk Lymphoma; 1996 Sep; 23(1-2):61-9. PubMed ID: 9021687
[TBL] [Abstract][Full Text] [Related]
28. Bone marrow stroma-derived PGE2 protects BCP-ALL cells from DNA damage-induced p53 accumulation and cell death.
Naderi EH; Skah S; Ugland H; Myklebost O; Sandnes DL; Torgersen ML; Josefsen D; Ruud E; Naderi S; Blomhoff HK
Mol Cancer; 2015 Jan; 14(1):14. PubMed ID: 25623255
[TBL] [Abstract][Full Text] [Related]
29. Viable bone marrow stromal cells are required for the in vitro survival of B-cell precursor acute lymphoblastic leukemic cells.
Ashley DM; Bol SJ; Kannourakis G
Leuk Res; 1995 Feb; 19(2):113-20. PubMed ID: 7869739
[TBL] [Abstract][Full Text] [Related]
30. Regeneration pattern of precursor-B-cells in bone marrow of acute lymphoblastic leukemia patients depends on the type of preceding chemotherapy.
van Lochem EG; Wiegers YM; van den Beemd R; Hählen K; van Dongen JJ; Hooijkaas H
Leukemia; 2000 Apr; 14(4):688-95. PubMed ID: 10764156
[TBL] [Abstract][Full Text] [Related]
31. Reactivity of acute lymphoblastic leukemia and normal bone marrow cells with the monoclonal anti-B-lymphocyte antibody, anti-Y 29/55.
Hirt A; Baumgartner C; Forster HK; Imbach P; Wagner HP
Cancer Res; 1983 Sep; 43(9):4483-5. PubMed ID: 6603266
[TBL] [Abstract][Full Text] [Related]
32. The imbalanced profile and clinical significance of T helper associated cytokines in bone marrow microenvironment of the patients with acute myeloid leukemia.
Sun YX; Kong HL; Liu CF; Yu S; Tian T; Ma DX; Ji CY
Hum Immunol; 2014 Feb; 75(2):113-8. PubMed ID: 24269703
[TBL] [Abstract][Full Text] [Related]
33. Quantitation of Human herpes virus 6 genome in children with acute lymphoblastic leukemia.
Seror E; Coquerel B; Gautheret-Dejean A; Ballerini P; Landman-Parker J; Leverger G; Schneider P; Vannier JP
J Med Virol; 2008 Apr; 80(4):689-93. PubMed ID: 18297709
[TBL] [Abstract][Full Text] [Related]
34. Bone marrow fibrosis in childhood acute lymphoblastic leukemia correlates to biological factors, treatment response and outcome.
Norén-Nyström U; Roos G; Bergh A; Botling J; Lönnerholm G; Porwit A; Heyman M; Forestier E
Leukemia; 2008 Mar; 22(3):504-10. PubMed ID: 18094715
[TBL] [Abstract][Full Text] [Related]
35. Proteomic tools and new insights for the study of B-cell precursor acute lymphoblastic leukemia.
Citalan-Madrid AF; Cabral-Pacheco GA; Martinez-de-Villarreal LE; Villarreal-Martinez L; Ibarra-Ramirez M; Garza-Veloz I; Cardenas-Vargas E; Marino-Martinez I; Martinez-Fierro ML
Hematology; 2019 Dec; 24(1):637-650. PubMed ID: 31514680
[TBL] [Abstract][Full Text] [Related]
36. Improving Stratification for Children With Late Bone Marrow B-Cell Acute Lymphoblastic Leukemia Relapses With Refined Response Classification and Integration of Genetics.
Eckert C; Groeneveld-Krentz S; Kirschner-Schwabe R; Hagedorn N; Chen-Santel C; Bader P; Borkhardt A; Cario G; Escherich G; Panzer-Grümayer R; Astrahantseff K; Eggert A; Sramkova L; Attarbaschi A; Bourquin JP; Peters C; Henze G; von Stackelberg A;
J Clin Oncol; 2019 Dec; 37(36):3493-3506. PubMed ID: 31644328
[TBL] [Abstract][Full Text] [Related]
37. Targeting bone marrow lymphoid niches in acute lymphoblastic leukemia.
Uy GL; Hsu YM; Schmidt AP; Stock W; Fletcher TR; Trinkaus KM; Westervelt P; DiPersio JF; Link DC
Leuk Res; 2015 Dec; 39(12):1437-42. PubMed ID: 26467815
[TBL] [Abstract][Full Text] [Related]
38. The immunophenotypes of blast cells in B-cell precursor acute lymphoblastic leukemia: how different are they from their normal counterparts?
Sędek Ł; Bulsa J; Sonsala A; Twardoch M; Wieczorek M; Malinowska I; Derwich K; Niedźwiecki M; Sobol-Milejska G; Kowalczyk JR; Mazur B; Szczepański T
Cytometry B Clin Cytom; 2014 Sep; 86(5):329-39. PubMed ID: 24845957
[TBL] [Abstract][Full Text] [Related]
39. Fast, In Vivo Model for Drug-Response Prediction in Patients with B-Cell Precursor Acute Lymphoblastic Leukemia.
Gauert A; Olk N; Pimentel-Gutiérrez H; Astrahantseff K; Jensen LD; Cao Y; Eggert A; Eckert C; Hagemann AIH
Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32668722
[TBL] [Abstract][Full Text] [Related]
40. Altered neutrophil immunophenotypes in childhood B‑cell precursor acute lymphoblastic leukemia.
Oliveira E; Bacelar TS; Ciudad J; Ribeiro MC; Garcia DR; Sedek L; Maia SF; Aranha DB; Machado IC; Ikeda A; Baglioli BF; Lopez-Duarte N; Teixeira LA; Szczepanski T; Silva ML; Land MG; Orfao A; Costa ES
Oncotarget; 2016 Apr; 7(17):24664-76. PubMed ID: 27028865
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
